Connecting you with bioscience health care solutions wherever you are in the world

/CONTRIBUTE

Contribute

BioLife is globalizing bioscience health care

BioLife tokens (BIOT) provide contributors with access to the best available biomedical resources and life science health care all around the world. This new on-chain system powered by distributed ledger technology opens a transparent marketplace for a wealth of customized bioscience treatments and therapies.

Why choose BioLife?

BIOT is the internal fuel currency and exclusive medium of exchange for transactions occurring within the BioLife digital ecosystem.

[2016 GLOBAL LIFE SCIENCES OUTLOOK, DELOITTE]

The size of the global digital health market was $60.8 billion USD in 2013 and is expected to increase to $233.3 billion USD in 2020.

The BioLife Token (BIOT)

As the native currency and exclusive medium of value exchange inside BioLife, BIOT is structured in a way that supports the entire BioLife digital ecosystem. In the context of token adoption, BIOT supports development within BioLife in many ways, including:

as an adopted exchange medium in the global bioscience and medical tourism marketplace

as a governance tool

as a reward for proposing and/or implementing new improvements to the platform

in the creation of a protocol layer for third-party applications

as a reward for valuable knowledge sharing

as a means of monetization for third-party vendors

as an access API to the BioLife platform

as a reward for securing the platform

This will increase liquidity of the whole BioLife ecosystem and steepen the velocity of BIOT as its native and exclusive currency. This may result in higher appreciation of BIOT as adoption expands and the platform becomes popular.

Exchanges

BioLife is working to secure multiple listings for BIOT across an array of cryptocurrency exchanges, to encourage frictionless exchange and usage for all global participants.

Token Generation Event

The TGE will be operated by SeroLab Laboratoire Suisse Holdings in Switzerland Ltd.
Commencing on August 11, 2018 at 0800UDT, the BIOT generation event will last one week or until tokens are sold. BioLife Tokens are in limited supply and BioLife may stop or extend the sale at any time without advanced notice. The BioLife TGE will be entrusted to an underwriter who will sell BIOT to contributors. 10 billion BIOT will be sold during the token generation event.

How to purchase BioLife Tokens

Contributors can buy BIOT with Ether (ETH), Bitcoin (BTC) or US Dollars (USD).

Lockup Period

There will be a lockup period of 45 days for the company reserve, early TGE, team pool, and early buyers. Principals and owners will not be permitted to execute trades of any tokens during this period.

Incentives to hold BIOT

After the 45-day lockup period concludes, everyone who purchased BIOT during the presale or the TGE will be given a 10% bonus for every BioLife Token held in cold storage and out of circulation for a period of 180 days.

KYC and AML jurisdiction regulation compliance

BioLife will comply ongoing with all KYC and AML regulations in particular jurisdictions.

Scaling and Streaming

Transaction times will be compressed and transaction fees kept low through BioLife's private payment channels as adoption increases and the platform scales.

Issuer

Swiss Vitality Cells Laboratory Limited.

Trusted Issuer

Zero Global Limited.

BioLife DApp buildout

The first BioLife DApps will be developed over twelve months, starting after conclusion of the TGE.

Clients will be able to access the BioLife DApps on their mobile or desktop devices in the same way they would any other app.

Ongoing support, maintenance, and further development of BioLife DApps will serve to invigorate the growing community.

Future Outlook

BioLife, through ongoing digitising of physical bioscience assets, and trade and exchange in BIOT, is aiming to promote the progress and sustainable development of life science and technology.

All parties willing to provide transparent services to their clients can participate in offline service scenarios.

Allocation of raised funds

Funds raised from the token sale will be allocated as follows: Raises will make use of brokers. Fees are 30% in round 1, 20% in round 2, and 10% in round 3. Cash raised will be used to build the BioLife ecosystem and provide cash advance against the fund, retrieving tokens in lieu when these are ready for release.